Sanofi-aventis Presents Phase 3 Trial Results Of Prostate Cancer Drug Cabazitaxel
The Tropic trial compared the combination of Cabazitaxel plus prednisone / prednisolone to the active agent mitoxantrone plus prednisone / prednisolone. For many patients with metastatic hormone-refractory prostate
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.